Consistently, knockdown of TNF-α in B-ALL-initiating cells or pharmacological inhibition of MMP-9 led to significant prolongation of survival in mice with B-ALL. This evidence concerns the gene TNF and precursor B-cell acute lymphoblastic leukemia.